358 filings
Page 5 of 18
8-K
60gf5bye
6 May 21
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
4:09pm
8-K
1pm4iliixww51d57i4
26 Apr 21
Entry into a Material Definitive Agreement
12:00am
424B3
00tk szwz7seg
23 Apr 21
Prospectus supplement
5:30pm
424B5
q3nnm5
23 Apr 21
Prospectus supplement for primary offering
5:28pm
S-8
at3i8450
26 Mar 21
Registration of securities for employees
4:22pm
8-K
l7ew tcuh
25 Mar 21
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
4:06pm
8-K
ms1wj45o pldlemo5s50
20 Jan 21
Departure of Directors or Certain Officers
8:01am
8-K
9kinu1v
4 Jan 21
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B5
z7cbu79id2bmn6g l192
23 Dec 20
Prospectus supplement for primary offering
5:05pm
EFFECT
a8u1yne5v
23 Dec 20
Notice of effectiveness
12:15am
CORRESP
hotq 1biev38
21 Dec 20
Correspondence with SEC
12:00am
UPLOAD
g03hbmg 9w8hps
21 Dec 20
Letter from SEC
12:00am
UPLOAD
p2v3cpx5bj
18 Dec 20
Letter from SEC
12:00am
8-K
23ny1v6iohuxd5mbe
17 Dec 20
Entry into a Material Definitive Agreement
7:07am
424B5
7fn l02pndpnaoqrtw
11 Dec 20
Prospectus supplement for primary offering
4:46pm